Skip to main content

Analyzing Trends in Oral Anticancer Agents in an Academic Medical Facility

Audiocasts - Practical Issues in Pharmacy Management
Jacob K. Kettle, PharmD, BCOP
Oncology Clinical Pharmacy Specialist,
Department of Pharmacy,
University of Missouri Health Care,
Columbia, MO
Jacob K Kettle, PharmD, BCOP, Oncology Clinical Pharmacy Specialist, Department of Pharmacy, University of Missouri Health Care, Columbia, MO, discusses the clinical significance of his study, “Analyzing Trends in Oral Anticancer Agents in an Academic Medical Facility.”
Related Items
Implementation of a Cardio-Oncology Pharmacist Position in a Community Cancer Center
JHOP - April 2026 Vol 16, No 2 published on January 2, 2026 in Practical Issues in Pharmacy Management, Adverse Events, Chemotherapy, Drug–Drug Interaction, Oncology Pharmacy Programs/Protocols, Oral Therapy
BCMA-Directed Bispecific Antibodies for Multiple Myeloma: Practical Approaches to Patient Management
JHOP - August 2025 Vol 15, No 4 published on August 20, 2025 in Review Article, Adverse Events, Multiple Myeloma, Practical Issues in Pharmacy Management
Financial Impact and Utilization of a Pharmacist-Driven Home Infusion Pathway for Blinatumomab in Patients Requiring Short-Term Inpatient Monitoring After Outpatient Initiation of Blinatumomab
JHOP - June 2025 Vol 15, No 3 published on June 11, 2025 in Practical Issues in Pharmacy Management, Leukemia
Biosimilar Utilization Management Within an Employee Health Plan Population
JHOP - December 2024 Vol 14, No 6 published on December 5, 2024 in Practical Issues in Pharmacy Management, Biosimilars, Oncology Pharmacy Programs/Protocols, Cost of Care
Locoregional CAR T Cells for the Treatment of CNS Tumors in Children: Investigational Drug Service Pharmacy Activities
JHOP - August 2024 Vol 14, No 4 published on August 2, 2024 in Practical Issues in Pharmacy Management, CAR T-Cell Therapy, Pediatric Cancer, Clinical Trials
Evaluation of Pharmacist-Driven Approach to Monitoring for Neutropenia Related to CDK4/6 Inhibitors in Women With Advanced Breast Cancer
JHOP - June 2024 Vol 14, No 3 published on May 23, 2024 in Practical Issues in Pharmacy Management, Oncology Pharmacy Programs/Protocols, Breast Cancer, CDK4/6 Inhibitors, Adverse Events
Biosimilars in Oncology Practice: A Multi-Site Health System Examination of the Use and Perception of Oncology Biosimilars
JHOP - April 2024 Vol 14, No 2 published on April 18, 2024 in Practical Issues in Pharmacy Management, Biosimilars, Cost of Care, Adverse Events
Enhancing Pharmacovigilance Methodologies in Patients With Cancer at Infusion Centers
JHOP - October 2023 Vol 13, No 5 published on October 17, 2023 in Practical Issues in Pharmacy Management, Oncology Pharmacy Programs/Protocols, Infusion Issues, Adverse Events, Technology
Clinical Role of Oncology Pharmacy Specialists in Oral Oncolytic Management in the Outpatient Hematology Clinic Setting
JHOP - October 2023 Vol 13, No 5 published on October 9, 2023 in Practical Issues in Pharmacy Management, Oncology Pharmacy Programs/Protocols, Oral Therapy, Chemotherapy, Supportive Care
Impact of Pharmacist-Led Oral Chemotherapy Telehealth Clinic at a Community Cancer Center Using the TAMER Model
JHOP - August 2023 Vol 13, No 4 published on August 17, 2023 in Practical Issues in Pharmacy Management, Chemotherapy, Technology, Oncology Pharmacy Programs/Protocols, Oral Therapy